Controlled drug delivery and cell adhesion for bone tissue regeneration by Keplerate polyoxometalate (Mo132)/metronidazole/PMMA scaffolds
Open Access
- 24 August 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-12
Abstract
The aim of this study is to fabricate a new scaffold appropriate for tissue regeneration with antimicrobial activity and ability of controlled drug delivery. In this regard, scaffold nanofibers were produced using poly (methyl methacrylate) (PMMA), Mo132 as a Keplerate polyoxometalate and metronidazole. The final scaffolds, obtained by electrospinning, represent the intrinsic features including exceptional doubling tensile strength, high hydrophilicity (126 ± 5.2° to 83.9 ± 3.2° for contact angle and 14.18 ± 0.62% to 35.62 ± 0.24% for water uptake), proper bioactivity and cell adhesion. Moreover, the addition of Mo132 and metronidazole enhances the biodegradation rate of resulted scaffolds compared to the pure PMMA membrane. The controlled release of metronidazole over 14 days efficiently inhibits the colonization of anaerobic microorganisms. Overall, the results demonstrate high potential of Mo132 and metronidazole-loaded PMMA scaffold for guided bone regeneration/guided tissue regeneration.Keywords
This publication has 57 references indexed in Scilit:
- Advances in drug delivery via electrospun and electrosprayed nanomaterialsInternational Journal of Nanomedicine, 2013
- Investigating the effect of PGA on physical and mechanical properties of electrospun PCL/PGA blend nanofibersJournal of Applied Polymer Science, 2011
- Mass and charge transfer in systems containing nanocluster molybdenum polyoxometallates with a fullerene structureRussian Journal of Physical Chemistry A, 2010
- Interaction of polyoxometalate Mo132 with poly(vinyl alcohol)Russian Journal of Inorganic Chemistry, 2009
- Synthetic Ion Channels via Self-Assembly: A Route for Embedding Porous Polyoxometalate Nanocapsules in Lipid Bilayer MembranesNano Letters, 2008
- Molecular Recognition of Basic Fibroblast Growth Factor by PolyoxometalatesAngewandte Chemie International Edition, 2005
- Molecular Recognition of Basic Fibroblast Growth Factor by PolyoxometalatesAngewandte Chemie, 2005
- Polyoxometalates: introduction to a class of inorganic compounds and their biomedical applicationsFrontiers in Bioscience-Landmark, 2005
- Polyoxometalates for molecular devices: Antitumor activity and luminescenceMolecular Imaging and Biology, 1993
- Drug residue formation from ronidazole, a 5-nitroimidazole. VIII. Identification of the 2-methylene position as a site of protein alkylationChemico-Biological Interactions, 1992